In a twist of fate, Apple has suspended the sales of its Apple Watch Series 9 and Ultra 2 in the United States due to an ongoing legal battle with health tech firm Masimo. The disagreement centers around the blood oxygen detection feature, leading to a ban imposed by the US International Trade Commission (USITC). Here’s a comprehensive overview of the unfolding situation:
Legal Turmoil and Regulatory Decisions
The USITC, responsible for overseeing trade matters, imposed a ban on the importation of the Series 9 and Ultra 2 following a judge’s ruling in January. This ruling asserted that Apple violated Masimo’s patents related to the blood oxygen sensing system. The ban, subject to presidential review until Dec. 25, was finalized on Dec. 26 after the US Trade Representative declined to reverse the USITC’s decision.
Significance for Apple
The Apple Watch stands as one of Apple’s pivotal products, propelling the wearables, home, and accessories business to become its second-largest product category after the iPhone. Apple’s preemptive move to pause online and in-store sales underscores the impact on its business during the crucial holiday shopping season.
Current Sales Landscape
While sales through Apple have been halted, the affected watches are still available on major retailers’ websites such as Best Buy, Amazon, Walmart, and Target. However, this availability may be temporary, as the order restricts Apple from importing and selling to resellers.
Legal Maneuvers and Proposed Redesign
Apple has taken the legal battle to the Federal Circuit and submitted a proposed redesign for approval by US Customs. The customs office is set to make a crucial decision on Jan. 12, determining whether Apple’s proposed changes infringe on Masimo’s patents.
Exploring Alternatives
For consumers seeking alternatives, the Apple Watch SE remains unaffected and is a viable option. Cross-platform compatible smartwatches like Fitbit Versa 4 and Garmin Venu 3 offer alternatives for those looking beyond the Apple ecosystem. Individuals specifically interested in monitoring blood oxygen levels at home may consider standalone pulse oximeters.
As this intricate legal saga unfolds, stay tuned for updates on Apple’s efforts to navigate the regulatory challenges and the potential resurgence of the Series 9 and Ultra 2 in the US market.